Singh Nikhilesh N 4
4 · Transcept Pharmaceuticals Inc · Filed Dec 5, 2011
Insider Transaction Report
Form 4
Singh Nikhilesh N
SVP & Chief Scientific Officer
Transactions
- Sale
Common Stock
2011-12-05$7.59/sh−13,237$100,469→ 1,554 total - Sale
Common Stock
2011-12-05$7.59/sh−36,709$278,621→ 0 total(indirect: See footnote)
Holdings
- 295(indirect: See footnote)
Common Stock
- 78,206(indirect: See footnote)
Common Stock
Footnotes (4)
- [F1]Shares held directly by the Nikhilesh and Nikki Singh Revocable Trust (the "Revocable Trust") for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Revocable Trust except to the extent of his pecuniary interest therein.
- [F2]Shares held directly by the Reporting Person's spouse.
- [F3]Shares held directly by the Singh Family Trust (the "Family Trust") for which Reporting Person's spouse serves as trustee. The Reporting Person disclaims beneficial ownership of the shares held by the Family Trust except to the extent of his pecuniary interest therein.
- [F4]The sales price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold within an estimated range from $8.16 to $7.20 per share. Upon request of the commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.